Trending...
- Premium Domain Name "Feedri.com" Now Available for Acquisition After $8,500 Offer
- Leadership Expert and Author Adam Holbrook Launches Breakthrough Book: Character Evolution
- Pregis Expands its Curbside-Recyclable Paper Packaging Portfolio with White EasyPack GeoTerra
FAYETTEVILLE, Ark. - nvtip -- Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China. These patents strengthen Lineus Medical's intellectual property portfolio as the company continues expanding into major healthcare markets worldwide. They also mark a key milestone toward obtaining regulatory clearances and establishing distribution partnerships in these regions.
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on nvtip.com
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
SafeBreak Vascular is the only break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on nvtip.com
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- CoreIntegrator Announces Sage Intacct Approved A/P One Integration, Becoming an Official Sage Partner
- GENIUS EDGE DEFI™ Distributed Energy Flexible Infrastructure
- Taylor Morrison to Expand Esplanade Brand to the Las Vegas Market with New Community
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
"Securing these new patents is a critical step in advancing the global presence of SafeBreak," said Vance Clement, CEO of Lineus Medical. "They not only protect our product from being copied and add value to the company, they also provide us credibility in establishing relationships with new distribution partners in these countries."
About Lineus Medical:
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
Source: Lineus Medical
Filed Under: Health, Technology
0 Comments
Latest on nvtip.com
- Carnegie Hall Hosts Theatrical Concert: El Dorado – A Musical Portrait of Edgar Allan Poe
- Fashion Icon Karl Kani Enters NIL Era with First-Ever Athlete Signing: King Kendrick
- Mental Health Watchdog Calling for a Ban on the Use of the Electroshock Machine in Florida
- Global Patient Organizations Applaud Historic Passage of a Resolution at WHA 78: "Skin diseases as a global public health priority"
- The Great Reset, the First Photorealistic AI Film Makes History at the Cannes Film Festival
- Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78
- Love, Laughter, And Legacy Collide In The Romantic Comedy "different With Me"
- RISE FESTIVAL INTRODUCES 'THE PATH' MEDITATIVE JOURNEY AND IMMERSIVE, LARGE-SCALE ART INSTALLATIONS
- Natalie Jean Releases Heartfelt Tribute Single "What They Didn't See" Honoring Late Friend and Lyricist Michael Peloso
- Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada
- Leadership Expert and Author Adam Holbrook Launches Breakthrough Book: Character Evolution
- Premium Domain Name "Feedri.com" Now Available for Acquisition After $8,500 Offer
- ADISA's 2025 Market Prediction Survey Results Show Major Surge in Revenue from Alternative Investments & Shift to 506(c) Offerings
- Comedy Legend Bob Zany Headlines Delirious Comedy Club on Fremont Street
- Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
- 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
- Use Dogecoin (DOGE) to mine Bitcoin (BTC) and earn passive income at home
- European Tech Startup RoarFun discovers a gap in the U.S. market with a branded racing simulator rental at Atlanta's MRO Americas Aviation Convention
- Degrees of Justice: Attorney Frank Walker Charts the Future of Criminal Justice with Ph.D Degree
- The Jesse Roldan Team and Biz Hub Financial Successfully Facilitate One-Day Closing for Investor Deal in Hellertown, PA